| Baruch David Gorman, MD | |
|
10075 S Jog Rd Ste 203, Boynton Beach, FL 33437-3536 | |
| (561) 767-9999 | |
| (855) 699-3535 |
| Full Name | Baruch David Gorman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 10075 S Jog Rd Ste 203, Boynton Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750358123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 121117 (New York) | Secondary |
| 207W00000X | Ophthalmology | ME155444 (Florida) | Primary |
| Entity Name | The New York Eye & Ear Infirmary Ophthalmology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811931041 PECOS PAC ID: 9032007968 Enrollment ID: O20040310000872 |
News Archive
Information security and privacy in the healthcare sector is an issue of growing importance but much remains to be done to address the various issues raised by healthcare consumers regarding privacy and security and the providers' perspective of regulatory compliance.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A new drug may boost the effectiveness of a widely used treatment for patients with non-Hodgkin lymphoma (NHL), while simultaneously overcoming drug resistance in those patients.
Daily vitamin E doses of 400 international units (IU) or more can increase the risk of death and should be avoided, researchers reported at the American Heart Association's Scientific Sessions 2004.
MorphoSys Obtains Additional U.S. Patents on Antibody Technologies MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) announced today that the U.S. Patent & Trademark Office has granted two new patents, which further strengthen the Company's IP portfolio.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Baruch David Gorman, MD 10075 S Jog Rd Ste 203, Boynton Beach, FL 33437-3536 Ph: (561) 767-9999 | Baruch David Gorman, MD 10075 S Jog Rd Ste 203, Boynton Beach, FL 33437-3536 Ph: (561) 767-9999 |
News Archive
Information security and privacy in the healthcare sector is an issue of growing importance but much remains to be done to address the various issues raised by healthcare consumers regarding privacy and security and the providers' perspective of regulatory compliance.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.
A new drug may boost the effectiveness of a widely used treatment for patients with non-Hodgkin lymphoma (NHL), while simultaneously overcoming drug resistance in those patients.
Daily vitamin E doses of 400 international units (IU) or more can increase the risk of death and should be avoided, researchers reported at the American Heart Association's Scientific Sessions 2004.
MorphoSys Obtains Additional U.S. Patents on Antibody Technologies MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) announced today that the U.S. Patent & Trademark Office has granted two new patents, which further strengthen the Company's IP portfolio.
› Verified 1 days ago
Miss Elizabeth Oteiza, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 N Congress Ave, Suite 104, Boynton Beach, FL 33426 Phone: 561-732-8005 Fax: 561-732-0150 | |
Dr. Garry Joseph Thomas, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1901 S Congress Ave, Suite 300, Boynton Beach, FL 33426 Phone: 561-602-7773 Fax: 561-336-2267 | |
Dr. Laura Rubinate, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11195 S Jog Rd # 1&2, Boynton Beach, FL 33437 Phone: 561-752-0075 | |
Dr. Deval Dinesh Joshi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10075 S Jog Rd, Suite 203, Boynton Beach, FL 33437 Phone: 561-767-9999 Fax: 855-699-3535 | |
Dr. Stephen Marc Robins, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10301 Hagen Ranch Rd Ste 500, Boynton Beach, FL 33437 Phone: 561-737-4040 Fax: 561-369-7104 | |
Dr. Jay R. Pechter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1880 N Congress Ave, Suite 309, Boynton Beach, FL 33426 Phone: 561-733-2388 | |
Dr. Lee Scott Friedman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Woolbright Rd, Boynton Beach, FL 33426 Phone: 561-737-5500 Fax: 561-737-7055 |